Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zani

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Cell Reports|May 26, 2022
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodiesShane Miersch, Nitin Sharma, Reza Saberianfar, et al.
Microorganisms|August 7, 2021
SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial CellsFrancesca Caccuri, Antonella Bugatti, Alberto Zani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2020
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietinFrancesca Caccuri, Pasqualina D'Ursi, Matteo Uggeri, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2022
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwideFrancesca Caccuri, Serena Messali, Alberto Zani, et al.
ACS Chemical Biology|June 22, 2022
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 VariantsJonathan M Labriola, Shane Miersch, Gang Chen, et al.
Fungal Genetics and Biology : FG & B|January 16, 2016
Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant populationMassimo Cogliati, Alberto Zani, Volker Rickerts, et al.
Viruses|May 27, 2023
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of ActionDaniela Iaconis, Francesca Caccuri, Candida Manelfi, et al.
Virus Evolution|June 16, 2022
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised hostFrancesca Caccuri, Serena Messali, Daria Bortolotti, et al.
Cell Death & Disease|May 25, 2022
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variantsDaniela Iaconis, Licia Bordi, Giulia Matusali, et al.
FEMS Yeast Research|May 19, 2016
Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basinMassimo Cogliati, Roberta D'Amicis, Alberto Zani, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Cell Reports|May 26, 2022
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodiesShane Miersch, Nitin Sharma, Reza Saberianfar, et al.
Microorganisms|August 7, 2021
SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial CellsFrancesca Caccuri, Antonella Bugatti, Alberto Zani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2020
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietinFrancesca Caccuri, Pasqualina D'Ursi, Matteo Uggeri, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2022
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwideFrancesca Caccuri, Serena Messali, Alberto Zani, et al.
ACS Chemical Biology|June 22, 2022
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 VariantsJonathan M Labriola, Shane Miersch, Gang Chen, et al.
Fungal Genetics and Biology : FG & B|January 16, 2016
Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant populationMassimo Cogliati, Alberto Zani, Volker Rickerts, et al.
Viruses|May 27, 2023
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of ActionDaniela Iaconis, Francesca Caccuri, Candida Manelfi, et al.
Virus Evolution|June 16, 2022
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised hostFrancesca Caccuri, Serena Messali, Daria Bortolotti, et al.
Cell Death & Disease|May 25, 2022
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variantsDaniela Iaconis, Licia Bordi, Giulia Matusali, et al.
FEMS Yeast Research|May 19, 2016
Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basinMassimo Cogliati, Roberta D'Amicis, Alberto Zani, et al.
Pageof 10